Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02192255 · ClinicalTrials.gov registry record · NA
SUPREME-DM (Diabetes Mellitis) Treatment Study
A NA study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 2,378
- Enrollment target
NCT02192255 is a NA study that has completed, run by HealthPartners Institute. The registered enrollment target is 2,378 participants.
The verdict
NCT02192255, a NA study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,378 participants
- Enrollment target
Study Summary
This multisite pragmatic clinical trial was designed to assess the effectiveness of a single scripted telephone call to diabetes patients who (a) were currently above recommended clinical goals for glucose, blood pressure, or lipids, and (b) had recently been prescribed a new medication for that specific clinical domain. The goals of the intervention were to improve primary adherence and persistence to the newly prescribed medication and to improve control of glucose, blood pressure, and lipids.
Interventions
- BEHAVIORAL Intervention Phone Call
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,378 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02192255
The ClinicalTrials.gov registry entry for NCT02192255 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,378 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intervention Phone Call is the first listed.
NCT02192255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02192255 about?
NCT02192255 is a clinical study titled "SUPREME-DM (Diabetes Mellitis) Treatment Study". This multisite pragmatic clinical trial was designed to assess the effectiveness of a single scripted telephone call to diabetes patients who (a) were currently above recommended clinical goals for glucose, blood pressure, or lipids, and (b) had recently been prescribed a new medication for that spe...
What is the current status of trial NCT02192255?
This trial is currently completed. It is a NA study. The enrollment target is 2,378 participants. The study started on 2012-01. Estimated completion is 2013-03.
What interventions are being tested in trial NCT02192255?
The interventions under investigation include: Intervention Phone Call (BEHAVIORAL).
Who is sponsoring clinical trial NCT02192255?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.